This platform enables protein-selective glycan editing in vivo, suggesting new strategies for glycosylation research.
Precise control of cell-surface glycosylation remains challenging due to the dynamic and spatially complex nature of glycans. Here, we present GLOBE, a platform for optical regulation of glycoenzyme activity via site-specific incorporation of photocaged unnatural amino acids. Using galactose oxidase (GAO) as a model, o-nitrobenzyl-tyrosine (ONBY) installed at a proximal tyrosine suppresses activity until photoactivation, enabling rapid cell-surface glycan oxidation with micrometer-scale spatial and temporal resolution. Coupling GAO with MUC1-targeting aptamer produces binding-gated, protein-selective glycan oxidation, achieving precise control in mixed cellular populations. GLOBE is further extended to in situ suppression of a sialidase catalytic domain, and integrated into an orthogonal photoresponsive cascade, where sialic acid removal exposes substrates for subsequent GAO oxidation, enhancing labeling efficiency. Finally, upconversion nanoparticle-assisted photoactivation enables in vivo glycan editing in a murine tumor model, overcoming UV tissue penetration limits. Together, GLOBE provides a modular, spatiotemporally programmable framework for probing and manipulating dynamic glycosylation at single-cell and tissue levels, offering a versatile strategy to interrogate and engineer the complex sugar code underlying biological and pathological processes.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: